Chiron appoints GPC in wake of flu-plant crisis
Biotech firm Chiron is understood to have appointed GPC International to its public affairs account after a competitive pitch as it recovers from controversy surrounding the suspension of its flu-vaccine facility in Liverpool this autumn.
Sign in to continue
Need to activate your subscription?
Domain/Group Subscriptions
Click here >>
Individual Subscriptions
Click here >>
Need to activate your Subscription
Company Wide Subscriptions
Click here >>
UK Individual Subscribers
Click here >>